165 related articles for article (PubMed ID: 31652191)
1. Clozapine and Norclozapine Plasma Levels in Patients Switched Between Different Liquid Formulations.
Oloyede E; Dzahini O; Whiskey E; Taylor D
Ther Drug Monit; 2020 Jun; 42(3):491-496. PubMed ID: 31652191
[TBL] [Abstract][Full Text] [Related]
2. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bioequivalence between clozapine suspension and tablet formulations : a multiple-dose, fed and fasted study.
Glue P; Gale C; Menkes DB; Hung N
Clin Drug Investig; 2012 Nov; 32(11):723-7. PubMed ID: 23018283
[TBL] [Abstract][Full Text] [Related]
4. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia.
Golden G; Honigfeld G
Clin Drug Investig; 2008; 28(4):231-9. PubMed ID: 18345713
[TBL] [Abstract][Full Text] [Related]
8. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
9. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients.
Mauri M; Volonteri LS; Fiorentini A; Invernizzi G; Nerini T; Baldi M; Bareggi SR
Schizophr Res; 2004 Feb; 66(2-3):197-8. PubMed ID: 15061256
[No Abstract] [Full Text] [Related]
11. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
12. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine.
Geers LM; Cohen D; Wehkamp LM; van Hateren K; Koster RA; Fedorenko OY; Semke AV; Bokhan N; Ivanova SA; Kosterink JGW; Loonen AJM; Touw DJ
J Clin Psychiatry; 2017; 78(9):e1211-e1218. PubMed ID: 29068609
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients.
Liu HC; Chang WH; Wei FC; Lin SK; Lin SK; Jann MW
Ther Drug Monit; 1996 Apr; 18(2):200-7. PubMed ID: 8721285
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
15. Intra-individual variation of clozapine and norclozapine plasma levels in clinical practice.
Turrion MC; Perez J; Bernardo M; Fernandez-Egea E
Rev Psiquiatr Salud Ment (Engl Ed); 2020; 13(1):31-35. PubMed ID: 31122757
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
Ming DS; Heathcote J
J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to quantitative LC-MS/MS: therapeutic drug monitoring of clozapine and norclozapine using isotopic internal calibration.
Couchman L; Belsey SL; Handley SA; Flanagan RJ
Anal Bioanal Chem; 2013 Nov; 405(29):9455-66. PubMed ID: 24091736
[TBL] [Abstract][Full Text] [Related]
18. Whole saliva and plasma levels of clozapine and desmethylclozapine.
Dumortier G; Lochu A; Zerrouk A; Van Nieuwenhuyse V; Colen de Melo P; Roche Rabreau D; Degrassat K
J Clin Pharm Ther; 1998 Feb; 23(1):35-40. PubMed ID: 9756110
[TBL] [Abstract][Full Text] [Related]
19. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
Lin SK; Su SF; Pan CH
Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
[TBL] [Abstract][Full Text] [Related]
20. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
